lobbying_activities: 3046424

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3046424	58035e7b-0ff6-4978-a86b-4c9f31105ccc	Q3	COVINGTON & BURLING LLP	11195	HORIZON THERAPEUTICS USA, INC. (FORMERLY HORIZON PHARMA USA, INC.)	2023	third_quarter	MMM	Drug pricing policies, including The Safe Step Act.	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2023-10-09T14:57:33-04:00